Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Out of this world cancer research. Human stem cells from Adelaide University's Centre for Cancer Biology hitched a ride to the edge of space aboard a German rocket — and made it back safely. Researchers will now study how microgravity affected the cells, hoping the findings could unlock new insights into cancer progression and early detection.
Australian cancer research just went to new heights — literally. Human stem cells from Adelaide University's Centre for Cancer Biology were launched aboard the German Aerospace Center's MAPHEUS-17 sounding rocket on October 1, 2026, from the Esrange Space Center in Sweden. The mission, led by South Australian company Cambrian Defense & Space, was carried out in partnership with the Centre for Cancer Biology, SSC Space, and Blue Dwarf Space, with backing from the South Australian Government.
The rocket soared to approximately 300 kilometers above Earth, giving the cells at least seven minutes of microgravity exposure before safely returning for recovery and analysis. Scientists will now examine how the cells responded to the weightless environment — and whether those changes could shed light on how cancer develops and how it might be detected earlier.
By the Numbers:
Why it matters: Microgravity has been shown to alter cell behavior in ways that can mimic disease states, making space a unique laboratory for studying cancer biology. If this mission yields meaningful data, it could open a new frontier in understanding — and potentially detecting — cancer earlier.